Clindamycin: Difference between revisions
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===General=== | ===General=== | ||
*PO: 150-450mg PO q6h | *'''PO:''' | ||
* | **150-450mg PO q6h | ||
* | **First Dose: 150-450mg PO x 1 | ||
** | *'''IM:''' | ||
**600-2700 mg/day IM divided q6-12h | |||
**First Dose: 600 mg IM x 1 | |||
**Max: 600 mg/dose | |||
*'''IV''' | |||
**600-2700 mg/day IV divided q6-12h | |||
**First Dose: 600-900 mg IV x 1 | |||
**IV: 4800 mg/day | **IV: 4800 mg/day | ||
Revision as of 14:50, 7 March 2014
General
- Type:
- Dosage Forms: IM, IV, PO (150mg; 300mg)
- Common Trade Names: Cleocin
Adult Dosing
General
- PO:
- 150-450mg PO q6h
- First Dose: 150-450mg PO x 1
- IM:
- 600-2700 mg/day IM divided q6-12h
- First Dose: 600 mg IM x 1
- Max: 600 mg/dose
- IV
- 600-2700 mg/day IV divided q6-12h
- First Dose: 600-900 mg IV x 1
- IV: 4800 mg/day
Pediatric Dosing
Special Populations
- Pregnancy:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: